Home
|
Learning Center
|
中文版
Publications
站内成果搜索:
搜索
Botulinum neurotoxin serotype D attacks neurons via two carbohydrate-binding sites in a ganglioside-dependent manner
Botulinum Toxin Type A for Painful Limbs Moving Extremities
Botulinum toxin type A reduces pain supersensitivity in experimental diabetic neuropathy: Bilateral effect after unilateral injection
Botulinum toxin versus submandibular duct relocation for severe drooling
Botulinum toxin improves reduced dorsiflexion after Achilles tendon surgery
Botulinum toxin for the treatment of headache: a promising path on a "dead end road"?
Botulinum Toxin Type A for Levodopa-Induced Cervical Dyskinesias in Parkinson's Disease: Unfavorable Risk-Benefit Ratio
Botulinum Toxin Type A for Nonsurgical Lateral Release in Patellofemoral Pain Syndrome: A Case Study
Botulinum Toxin Outcomes for Idiopathic Overactive Bladder Stratified by Indication: Lack of Anticholinergic Efficacy Versus Intolerability
Botulinum neurotoxin subtype A2 enters neuronal cells faster than subtype A1
Botulinum toxin historical aspects: from food poisoning to pharmaceutical
Botulinum toxin injections for adults with overactive bladder syndrome
Botulism Challenge Studies of a Modified Atmosphere Package for Fresh Mussels: Inoculated Pack Studies
Botulinum Toxin A Versus Placebo for Refractory Detrusor Overactivity in Women: A Randomised Blinded Placebo-Controlled Trial of 240 Women (the RELAX Study)
Botulinum toxin treatment for overactive bladder and detrusor overactivity in adults
Botulinum Toxin Injection for the Management of Refractory Filamentary Keratitis
Botulinum toxin in %26quot;refractory%26quot; detrusor overactivity. Re: Makovey I, et al. Botulinum toxin outcomes for idiopathic overactive bladder stratified by indication: Lack of anticholinergic efficacy versus intolerability. Neurourol Urodyn 2011;30:1538-1540
Botulinum Neurotoxin A Decreases Infiltrating Cutaneous Lymphocytes and Improves Acanthosis in the KC-Tie2 Mouse Model
Botulinum Toxin A in the Treatment of Myofascial Pain and Dysfunction: The Case Against Its Use
Botulinum Toxin a in Prostate Disease: A Venom from Bench to Bed-Side
Botulinum toxin A modulates afferent fibers in neurogenic detrusor overactivity
Botulinum Neurotoxins A and E Undergo Retrograde Axonal Transport in Primary Motor Neurons
Botulinum toxin in the treatment of post-radiosurgical neck contracture in head and neck cancer: A novel approach
Botulinum toxin injections: A new therapeutic avenue in urology
Botulinum toxin A in chronic refractory migraine: premarketing experience
Botulinum toxin A: dose and immune response
Botulism by Clostridium botulinum type C in goats associated with osteophagia
Botulinum toxin%26apos;s axonal transport from periphery to the spinal cord
Botulinum toxin in hemifacial spasm: the challenge to assess the effect of treatment
Botulinum Toxin A for Oral Cavity Cancer Patients: In Microsurgical Patients BTX Injections in Major Salivary Glands Temporarily Reduce Salivary Production and the Risk of Local Complications Related to Saliva Stagnation
Botulinum Toxin Injections Into Salivary Glands to Decrease Oral Secretions in CHARGE Syndrome: Prospective Case Study
Botulinum toxin type A should be PBS listed for treatment of palmar hyperhidrosis
Botulinum toxin A for the Treatment of Overactive Bladder
Botulinum and Tetanus Neurotoxin-Induced Blockade of Synaptic Transmission in Networked Cultures of Human and Rodent Neurons
Botulinum toxin in trigeminal neuralgia
Botulinum toxin in the management of chronic migraine: clinical evidence and experience
Botulinum Toxin A: Evolving Treatment Strategies for the Chronic Pelvic Pain Patient
Botulinum Neurotoxins: Biology, Pharmacology, and Toxicology
Botulinum neurotoxin C mutants reveal different effects of syntaxin or SNAP-25 proteolysis on neuromuscular transmission
Botulinum toxin and rehabilitation treatment in inclusion body myositis for severe oropharyngeal dysphagia
Botulinum Neurotoxin A for Parotid Enlargement in Cystic Fibrosis: The First Case Report
Botulinum Toxin Conjugated With Silk Fibroin and 4-Hexylresorcinol
Botulinum Toxin for Neck Rejuvenation: Assessing Efficacy and Redefining Patient Selection
Botulinum Toxin Treatment in Neurology: Indications, Technique and Ultrasound-Guidance
Botulinum Neurotoxin A Treatment for Spasticity and Dystonia - What is New?
Botulinum Toxin Treatment of Blepharospasm, Orofacial/Oromandibular Dystonia, and Hemifacial Spasm
Botulinum toxin treatment for facial palsy: A systematic review
Botulinum Toxin Injection for the Treatment of Delayed Gastric Emptying Following Pylorus-Preserving Gastrectomy: an Initial Experience
Botulinum toxin type A in motor nervous system: unexplained observations and new challenges
Botulinum toxin type b for the treatment of a sialocele after parotidectomy
Botulinum toxin type A for the treatment of non-neurogenic overactive bladder: does using onabotulinumtoxinA (Botox (R)) or abobotulinumtoxinA (Dysport (R)) make a difference?